• [email protected]
  • +971 507 888 742
Submit Manuscript
SciAlert
  • Home
  • Journals
  • Information
    • For Authors
    • For Referees
    • For Librarian
    • For Societies
  • Contact
  1. International Journal of Pharmacology
  2. Vol 1 (3), 2005
  3. 210-225
  • Online First
  • Current Issue
  • Previous Issues
  • More Information
    Aims and Scope Editorial Board Guide to Authors Article Processing Charges
    Submit a Manuscript

International Journal of Pharmacology

Year: 2005 | Volume: 1 | Issue: 3 | Page No.: 210-225
DOI: 10.3923/ijp.2005.210.225

Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

Article Trend



Total views 152

Authors


Anna Jamroz-Wisniewska


Jerzy Bettowski


Keywords


Research Article

Adverse Effects of Statins

Anna Jamroz-Wisniewska and Jerzy Bettowski
Statins are competitive inhibitors of 3-hydroxy-3-methylglutarylcoenzyme A (HMG-CoA) reductase, the rate-limiting enzyme in cholesterol biosynthesis pathway, which converts HMG-CoA to mevalonate. Statins lower plasma Low Density Lipoprotein (LDL)-bound cholesterol by causing intracellular cholesterol depletion and upregulating the expression of LDL receptors. Apart from cholesterol, mevalonate is also used as the substrate for the synthesis of nonsteroid isoprenoids including farnesylpyrophosphate, geranylgeranylpyrophosphate (both attached to small GTP-binding proteins by protein prenyltransferases), coenzyme Q, dolichol, isopentenylpyrophosphate, etc. Inhibiting the synthesis of these nonsteroid isoprenoids results in so called "pleiotropic" effects of statins which are independent of cholesterol lowering. Although statins are generally well-tolerated, adverse effects may occur in some patients. Myopathy is the most frequent side effect of statins. Other less common include peripheral neuropathy, hepatotoxicity, increased risk of cataract and, according to some studies, increased risk of breast cancer. Some studies suggest that under specific experimental conditions statins may exert detrimental effects also on processes which are generally believed to be favorably modified by these drugs, e.g. vascular reactivity, myocardial performance or atherogenesis. In this review currently recognized mechanisms through which statins could induce side effects are discussed.
PDF References Citation

How to cite this article

Anna Jamroz-Wisniewska and Jerzy Bettowski, 2005. Adverse Effects of Statins. International Journal of Pharmacology, 1: 210-225.

DOI: 10.3923/ijp.2005.210.225

URL: https://scialert.net/abstract/?doi=ijp.2005.210.225

Related Articles

Bayesian Meta-Analysis: The Effect of Statins on the Treatment of Hypercholesterolemia
Mitigation of Septic Signs by Pravastatin during LPS Co-Administered Hen-Egg White Lysozyme Immunization in Mice
Moderation of Immunopathological Parameters by Pravastatin in Pasteurella multocida (Pm52) Induced Septicaemic Mice

Leave a Comment


Your email address will not be published. Required fields are marked *

Useful Links

  • Journals
  • For Authors
  • For Referees
  • For Librarian
  • For Socities

Contact Us

Office Number 1128,
Tamani Arts Building,
Business Bay,
Deira, Dubai, UAE

Phone: +971 507 888 742
Email: [email protected]

About Science Alert

Science Alert is a technology platform and service provider for scholarly publishers, helping them to publish and distribute their content online. We provide a range of services, including hosting, design, and digital marketing, as well as analytics and other tools to help publishers understand their audience and optimize their content. Science Alert works with a wide variety of publishers, including academic societies, universities, and commercial publishers.

Follow Us
© Copyright Science Alert. All Rights Reserved